Federal Circuit Decision Clarifies When an ANDA Filer May Appeal an Adverse IPR Ruling
By EsqSocial Corporation 28/01/19
In Amerigen Pharmaceuticals Limited v. UCB Pharma GmbH, generic drug manufacturer Amerigen appealed a decision of the Patent Trial & Appeal Board finding UCB’s patent to certain chemical derivatives of diphenylpropylamines not invalid. The court...
By: Akin Gump Strauss Hauer & Feld LLP